These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22108801)

  • 41. TSH is a negative regulator of skeletal remodeling.
    Abe E; Marians RC; Yu W; Wu XB; Ando T; Li Y; Iqbal J; Eldeiry L; Rajendren G; Blair HC; Davies TF; Zaidi M
    Cell; 2003 Oct; 115(2):151-62. PubMed ID: 14567913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling?
    Van Bezooijen RL; Papapoulos SE; Löwik CW
    Bone; 2001 Apr; 28(4):378-86. PubMed ID: 11336918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts.
    Lademann F; Rijntjes E; Köhrle J; Tsourdi E; Hofbauer LC; Rauner M
    Commun Biol; 2024 May; 7(1):548. PubMed ID: 38719881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone.
    Sakamoto A; Chen M; Nakamura T; Xie T; Karsenty G; Weinstein LS
    J Biol Chem; 2005 Jun; 280(22):21369-75. PubMed ID: 15797856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.
    Wang F; Zhang C; Ge W; Zhang G
    J Cell Mol Med; 2019 Oct; 23(10):6744-6754. PubMed ID: 31402549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
    Ye C; Hou W; Chen M; Lu J; Chen E; Tang L; Hang K; Ding Q; Li Y; Zhang W; He R
    Cell Prolif; 2020 Feb; 53(2):e12752. PubMed ID: 31889368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G; Xu Q; Dai M; Liu X
    Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
    Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
    Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling.
    Edwards JR; Perrien DS; Fleming N; Nyman JS; Ono K; Connelly L; Moore MM; Lwin ST; Yull FE; Mundy GR; Elefteriou F
    J Bone Miner Res; 2013 Apr; 28(4):960-9. PubMed ID: 23172686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss.
    Onal M; Xiong J; Chen X; Thostenson JD; Almeida M; Manolagas SC; O'Brien CA
    J Biol Chem; 2012 Aug; 287(35):29851-60. PubMed ID: 22782898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ST2 regulates bone loss in a site-dependent and estrogen-dependent manner.
    Macari S; Madeira MFM; Lima ILA; Pereira TSF; Dias GJ; Cirelli JA; de Molon RS; Fukada SY; Szawka RE; Garlet GP; Teixeira MM; Silva TA
    J Cell Biochem; 2018 Nov; 119(10):8511-8521. PubMed ID: 30011081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biglycan deficiency interferes with ovariectomy-induced bone loss.
    Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
    J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
    Tudpor K; van der Eerden BC; Jongwattanapisan P; Roelofs JJ; van Leeuwen JP; Bindels RJ; Hoenderop JG
    Bone; 2015 Mar; 72():14-22. PubMed ID: 25460576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover.
    Braun T; Lepper J; Ruiz Heiland G; Hofstetter W; Siegrist M; Lezuo P; Gaestel M; Rumpler M; Thaler R; Klaushofer K; Distler JH; Schett G; Zwerina J
    J Bone Miner Res; 2013 Apr; 28(4):936-47. PubMed ID: 23169443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positive regulation of osteogenesis by bile acid through FXR.
    Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
    J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.